|
시장보고서
상품코드
2051404
안구건조증 치료제 시장 : 제품 유형별, 제형별, 판매채널별, 지역별Dry Eye Disease Market, By Product Type, By Formulation Type, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
안구건조증 질환 시장은 2026년에 87억 3,000만 달러로 추정되고, 2033년까지 161억 6,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.2%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 87억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.20% | 2033년 시장 규모 예측 : | 161억 6,000만 달러 |
안구건조증(건성각결막염)은 눈물 및 안구 표면에 발생하는 다인성 질환으로 불편감, 시력장애, 눈물층 불안정 등의 증상을 유발하고 눈꺼풀 사이 안구 표면에 손상을 줄 수 있습니다. 이는 눈물층의 삼투압 상승과 안구 표면의 염증을 동반합니다. 안구건조증은 고령화와 디지털 기기 사용 증가로 인해 눈을 깜빡이는 횟수가 줄어들고 눈을 뜨고 있는 시간이 길어지면서 전 세계적으로 심각해지고 있는 문제입니다. 안구건조증은 흔히 경미하고 귀찮은 질환으로 여겨지지만, 삶의 질과 생산성에 악영향을 미칠 수 있습니다.
시장 역학
세계 안구건조증 시장은 노화에 따른 눈물 분비량 감소로 인해 안구건조증에 영향을 많이 받는 고령 인구 증가에 의해 주도되고 있습니다. 또한 스마트폰, 노트북, 태블릿 등 디지털 기기의 장시간 사용은 눈에 큰 부담을 주고 안구건조증을 유발하고 있으며, 이는 시장 성장을 견인하고 있습니다. 그러나 특히 개발도상국에서는 안구건조증 치료법, 자가 관리 및 관리에 대한 인식이 낮은 것이 시장 성장의 걸림돌로 작용하고 있습니다. 시장 진출기업들은 안구건조증의 증상과 징후를 모두 해결하기 위해 인공눈물의 혁신적인 투여 방법이나 병용 요법 등 제품 개발의 새로운 가능성을 모색할 수 있는 기회를 얻게 되었습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 안구건조증 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 안구건조증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 안구건조증 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 안구건조증 치료제 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 안구건조증 치료제 시장 : 제제 유형별, 2021년-2033년
제6장 세계의 안구건조증 치료제 시장 : 유통 채널별, 2021년-2033년
제7장 세계의 안구건조증 치료제 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 견해
제10장 참고 문헌 및 조사 방법
LSH 26.06.18Dry Eye Disease Market is estimated to be valued at USD 8.73 Bn in 2026 and is expected to reach USD 16.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.73 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.20% | 2033 Value Projection: | USD 16.16 Bn |
Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the interpalpebral ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface. Dry eye disease is a growing problem worldwide due to aging populations and greater use of digital devices, leading to decreased blink rates and more time spent with eyes open. Although often thought of as a mild, nuisance disease, dry eye can negatively impact quality of life and productivity.
Market Dynamics
The global dry eye disease market is driven by the rising geriatric population globally which is majorly affected by dry eye disease due to age-related decreasing tear production. Furthermore, increasing usage of digital devices, such as smartphones, laptops, and tablets, for extended periods are majorly straining eyes leading to dry eyes, thereby driving the market growth. However, lack of awareness about treatment options, self-care, and management of dry eye disease especially in developing nations act as major market restraints. Market participants have the chance to explore new avenues in product development, including innovative delivery methods for artificial tears and combination therapies aimed at addressing both the signs and symptoms of dry eye disease.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global dry eye disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Novartis AG, Alcon Inc., I-MED Pharma Inc, Sun Pharmaceutical Industries Ltd., Novaliq GmbH, Cipla Inc., AbbVie Inc., Lupin, Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd, Cambium Medical Technologies, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Abbott, Adrif Vision, Grevis Pharmaceuticals Pvt. Ltd., AFT Pharmaceuticals, URSAPHARM Arzneimittel GmbH, and Altacor.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global dry eye disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dry eye disease market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Cyclosporine
- Corticosteroids
- Lifitegrast
- Ocular Lubricant
- Punctal Plugs
- Others
- Formulation Type Insights (Revenue, USD Bn, 2026 - 2033)
- Liquid
- Gel
- Ointment
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Supermarket/Hypermarket
- Other Stores
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis AG
- Alcon Inc.
- I-MED Pharma Inc
- Sun Pharmaceutical Industries Ltd.
- Novaliq GmbH
- Cipla Inc.
- AbbVie Inc.
- Lupin
- Otsuka Holdings Co., Ltd.
- Santen Pharmaceutical Co., Ltd
- Cambium Medical Technologies
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
- Abbott
- Adrif Vision
- Grevis Pharmaceuticals Pvt. Ltd.
- AFT Pharmaceuticals
- URSAPHARM Arzneimittel GmbH
- Altacor
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Formulation Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Dry Eye Disease Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cyclosporine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Lifitegrast
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ocular Lubricant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Punctal Plugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Dry Eye Disease Market, By Formulation Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ointment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Dry Eye Disease Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Supermarket/Hypermarket
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Dry Eye Disease Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alcon Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- I-MED Pharma Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novaliq GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Otsuka Holdings Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Santen Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambium Medical Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Viatris Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch & Lomb Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Adrif Vision
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Grevis Pharmaceuticals Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AFT Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- URSAPHARM Arzneimittel GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Altacor
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
